FDA significantly limits access to COVID-19 vaccines News Health & Medicine FDA significantly limits access to COVID-19 vaccines The agency is restricting new shots to people ages 65 and up or with underlying conditions FDA is..."> FDA significantly limits access to COVID-19 vaccines News Health & Medicine FDA significantly limits access to COVID-19 vaccines The agency is restricting new shots to people ages 65 and up or with underlying conditions FDA is..." /> FDA significantly limits access to COVID-19 vaccines News Health & Medicine FDA significantly limits access to COVID-19 vaccines The agency is restricting new shots to people ages 65 and up or with underlying conditions FDA is..." />

Upgrade to Pro

FDA significantly limits access to COVID-19 vaccines

News

Health & Medicine

FDA significantly limits access to COVID-19 vaccines

The agency is restricting new shots to people ages 65 and up or with underlying conditions

FDA is restricting access to new COVID-19 vaccines, limiting options for younger people who want to get the shots.

South_agency/Getty Images

By McKenzie Prillaman
7 seconds ago

The U.S. Food and Drug Administration is changing its policy on who should get COVID-19 shots, potentially limiting access to new vaccine formulations as they enter the market.
New and updated jabs will be approved only for people ages 65 and up, as well as those between 6 months and 64 years with at least one medical condition that heightens their risk for severe outcomes, according to the new FDA framework unveiled May 20 in the New England Journal of Medicine. Between 100 million and 200 million Americans would still be covered through this approval method, the framework authors say.

Sign up for our newsletter

We summarize the week's scientific breakthroughs every Thursday.
#fda #significantly #limits #access #covid19
FDA significantly limits access to COVID-19 vaccines
News Health & Medicine FDA significantly limits access to COVID-19 vaccines The agency is restricting new shots to people ages 65 and up or with underlying conditions FDA is restricting access to new COVID-19 vaccines, limiting options for younger people who want to get the shots. South_agency/Getty Images By McKenzie Prillaman 7 seconds ago The U.S. Food and Drug Administration is changing its policy on who should get COVID-19 shots, potentially limiting access to new vaccine formulations as they enter the market. New and updated jabs will be approved only for people ages 65 and up, as well as those between 6 months and 64 years with at least one medical condition that heightens their risk for severe outcomes, according to the new FDA framework unveiled May 20 in the New England Journal of Medicine. Between 100 million and 200 million Americans would still be covered through this approval method, the framework authors say. Sign up for our newsletter We summarize the week's scientific breakthroughs every Thursday. #fda #significantly #limits #access #covid19
WWW.SCIENCENEWS.ORG
FDA significantly limits access to COVID-19 vaccines
News Health & Medicine FDA significantly limits access to COVID-19 vaccines The agency is restricting new shots to people ages 65 and up or with underlying conditions FDA is restricting access to new COVID-19 vaccines, limiting options for younger people who want to get the shots. South_agency/Getty Images By McKenzie Prillaman 7 seconds ago The U.S. Food and Drug Administration is changing its policy on who should get COVID-19 shots, potentially limiting access to new vaccine formulations as they enter the market. New and updated jabs will be approved only for people ages 65 and up, as well as those between 6 months and 64 years with at least one medical condition that heightens their risk for severe outcomes, according to the new FDA framework unveiled May 20 in the New England Journal of Medicine. Between 100 million and 200 million Americans would still be covered through this approval method, the framework authors say. Sign up for our newsletter We summarize the week's scientific breakthroughs every Thursday.
·82 Ansichten